Researcher profile

Jing Xiang

Jing Xiang contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 11 - UnverifiedVerification L1Unclaimed author
1works
0followers
1topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2026arXiv

A Synoptic Review of High-Frequency Oscillations as a Biomarker in Neurodegenerative Disease

High Frequency Oscillations (HFOs), rapid bursts of brain activity above 80 Hz, have emerged as a highly specific biomarker for epileptogenic tissue. Recent evidence suggests that HFOs are also present in Alzheimer's Disease (AD), reflecting underlying network hyperexcitability and offering a promising, noninvasive tool for early diagnosis and disease tracking. This synoptic review provides a comprehensive analysis of publicly available electroencephalography (EEG) datasets relevant to HFO research in neurodegenerative disorders. We conducted a bibliometric analysis of 1,222 articles, revealing a significant and growing research interest in HFOs, particularly within the last ten years. We then systematically profile and compare key public datasets, evaluating their participant cohorts, data acquisition parameters, and accessibility, with a specific focus on their technical suitability for HFO analysis. Our comparative synthesis highlights critical methodological heterogeneity across datasets, particularly in sampling frequency and recording paradigms, which poses challenges for cross-study validation, but also offers opportunities for robustness testing. By consolidating disparate information, clarifying nomenclature, and providing a detailed methodological framework, this review serves as a guide for researchers aiming to leverage public data to advance the role of HFOs as a cross-disease biomarker for AD and related conditions.